Long-COVID and long-term cancer survivorship—Shared lessons and opportunities

DOI

10.1111/ecc.13712

Document Type

Journal Article

Publication Date

1-1-2022

Publication Title

European Journal of Cancer Care

ISSN

9615423

Keywords

cancer, cancer survivorship, COVID-19

Abstract

As of 2022, close to 90 million persons in the United States, 243 million persons in Europe and 585 million worldwide have been infected with the novel SARS-CoV-2 (COVID-19) virus and survived. Estimates vary but suggest that up to 50% may experience long-term sequelae, termed ‘Long-COVID’. While Long-COVID is a new condition, the phenomenon of disabling long-term effects following an illness requiring ongoing surveillance and management is not. In this commentary, we discuss how Long-COVID parallels the experiences of long-term cancer survivors, highlight shared challenges and offer opportunities to improve research and clinical care for both growing populations of patients as well as other long-term chronic, disabling conditions.

Open Access

Green Final

Link to Full Text

Share

COinS